Regeneron Pharmaceuticals, Inc.
REGN
$903.48
$12.821.44%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 40.07% | 41.19% | 17.99% | 27.08% | 35.96% |
Total Receivables | 6.35% | 0.65% | -0.78% | 5.78% | -11.73% |
Inventory | 7.44% | 6.21% | 13.04% | 21.75% | 23.09% |
Prepaid Expenses | -5.98% | 28.74% | -38.18% | -4.40% | 23.71% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 22.63% | 20.78% | 8.97% | 18.20% | 13.34% |
|
|||||
Total Current Assets | 22.63% | 20.78% | 8.97% | 18.20% | 13.34% |
Net Property, Plant & Equipment | 10.18% | 8.15% | 7.83% | 9.12% | 10.11% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 13.45% | 26.50% | -- | -- | 13,564.18% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 47.75% | 54.63% | 55.77% | 64.22% | 84.29% |
Total Assets | 13.23% | 16.21% | 12.69% | 14.08% | 14.86% |
|
|||||
Total Accounts Payable | 2.95% | 0.19% | 2.45% | 27.47% | 4.47% |
Total Accrued Expenses | 12.75% | 41.02% | 12.89% | 1.38% | 28.96% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 53.23% | -- | -- | -- | -98.28% |
Total Finance Division Other Current Liabilities | -0.78% | -3.36% | -33.39% | -13.23% | -54.03% |
Total Other Current Liabilities | -0.78% | -3.36% | -33.39% | -13.23% | -54.03% |
Total Current Liabilities | 8.98% | 24.99% | 2.32% | 3.08% | -20.12% |
|
|||||
Total Current Liabilities | 8.98% | 24.99% | 2.32% | 3.08% | -20.12% |
Long-Term Debt | 0.08% | 0.08% | 0.08% | 0.07% | 0.07% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.66% | 0.00% | 0.00% | 0.00% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 39.89% | 45.39% | 6.33% | 5.07% | -13.47% |
Total Liabilities | 8.50% | 16.35% | 1.87% | 2.03% | -1.73% |
|
|||||
Common Stock & APIC | 14.12% | 18.21% | 19.39% | 21.06% | 23.02% |
Retained Earnings | 16.96% | 18.05% | 20.67% | 20.97% | 22.87% |
Treasury Stock & Other | -19.35% | -22.17% | -29.67% | -27.85% | -27.81% |
Total Common Equity | 14.60% | 16.17% | 16.10% | 17.98% | 20.75% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.60% | 16.17% | 16.10% | 17.98% | 20.75% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 14.60% | 16.17% | 16.10% | 17.98% | 20.75% |
|